Cancer and Tumor Marker Men's Screening

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

The Amylase Test measures amylase enzyme levels in blood to evaluate pancreatic and digestive health. Elevated amylase may indicate pancreatitis, gallbladder disease, intestinal blockage, or salivary gland disorders, while low levels may suggest chronic pancreatitis or liver damage. Doctors order this test to investigate abdominal pain, nausea, or fever. Results provide vital insight into pancreatic function, digestive disorders, and overall metabolic health.

The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.

The CA 19-9 Test measures levels of carbohydrate antigen 19-9 in blood, a tumor marker often elevated in pancreatic cancer and sometimes in bile duct, colorectal, or liver cancers. While not used alone for diagnosis, it helps monitor treatment, track disease progression, and detect recurrence. Elevated CA 19-9 may also occur in noncancerous conditions. Doctors use this test to support cancer management and guide therapy decisions.

The Calcitonin Test measures levels of calcitonin, a hormone produced by the thyroid gland that helps regulate calcium. Elevated levels are often linked to medullary thyroid carcinoma (MTC) or other thyroid disorders, while normal results help rule out disease. Doctors use this blood test to aid in early detection, monitor treatment effectiveness, and track recurrence in patients with thyroid cancer or suspected endocrine abnormalities.

The CEA Test measures carcinoembryonic antigen levels in blood, a protein that may be elevated in certain cancers, especially colorectal, pancreatic, lung, breast, or ovarian cancer. It is not used alone for diagnosis but helps monitor cancer treatment, detect recurrence, and track disease progression. Elevated CEA can also occur in noncancerous conditions. Doctors use this test to support therapy decisions and provide insight into cancer management.

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Culture Urine Routine Test detects and identifies bacteria or yeast in urine that cause urinary tract infections (UTIs). By growing microorganisms in a lab, this test determines the type of infection and guides effective treatment. Doctors use it to evaluate symptoms such as painful urination, frequent urges, or fever and to monitor recurrent UTIs. Results provide critical insight for diagnosis, antibiotic selection, and urinary health management.

The DCP Test detects des-gamma-carboxy prothrombin, an abnormal form of prothrombin linked to hepatocellular carcinoma and other liver disorders. Elevated levels may reflect tumor activity, chronic liver disease, or cirrhosis. This test provides valuable information for assessing liver function, monitoring cancer progression, and evaluating systemic health in patients with hepatic disease.

The Fecal Globin by Immunochemistry Test detects hidden (occult) blood in stool using antibodies that identify human globin protein. This test helps screen for colorectal cancer, polyps, ulcers, and gastrointestinal bleeding. Doctors order it when patients have anemia, abdominal pain, or changes in bowel habits. Results provide early detection of digestive tract bleeding, guiding further evaluation with colonoscopy or other diagnostic procedures.

The Gastrin Test measures gastrin hormone levels in blood, which regulate stomach acid production. Elevated levels may indicate Zollinger-Ellison syndrome, gastrinoma, pernicious anemia, or chronic atrophic gastritis. Doctors order this test for patients with recurrent ulcers, abdominal pain, or unexplained diarrhea. Results help evaluate abnormal acid production, detect tumors, and guide treatment for gastrointestinal and metabolic conditions.

The hCG Total Quantitative Test measures human chorionic gonadotropin levels in blood to confirm pregnancy and monitor its progression. It provides exact hCG values, helping detect ectopic pregnancy, miscarriage risk, and abnormal growths like trophoblastic disease. Doctors also use it to track fertility treatments and evaluate certain cancers. This test offers precise insight into pregnancy health, reproductive function, and overall hormone balance.

The Lactate Dehydrogenase (LDH) Test measures LDH enzyme levels in blood to assess tissue damage and overall health. Elevated LDH may indicate conditions such as liver disease, heart attack, anemia, infections, or certain cancers, while low levels are uncommon. Doctors use this test to help diagnose disease, monitor treatment effectiveness, and track cell damage. It provides valuable insight into metabolic activity and organ function.

The PSA Total Test measures prostate-specific antigen levels in blood to evaluate prostate health. Elevated PSA may indicate prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. Doctors use this test for early detection of prostate cancer, monitoring treatment, or assessing recurrence risk. Commonly recommended for men over 50 or those at higher risk, the PSA test supports diagnosis, prevention, and long-term prostate care.

The PSA Free and Total Test measures prostate-specific antigen in blood, reporting both free and total PSA to help evaluate prostate health. It is used to screen for prostate cancer, differentiate between cancer and benign conditions like prostatitis or enlarged prostate (BPH), and monitor treatment. Doctors order this test for men with urinary symptoms or at risk of prostate disease. Results provide key insight into prostate function and overall men’s health.